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INTRODUCTION
Pathologic changes in the glomerular extracellular matrix
lead to abnormal protein excretion as well as to impairment
of glomerular filtration in diabetic nephropathy. Alterations
in the diabetic glomerular basement membrane include in-
crease in its thickness and decrease in the density of anionic
sites (1). The latter corresponds to reduction in glomerular
basement membrane content of heparan sulfate proteoglycan
(HSPG), a highly anionic molecule which regulates the charge-
and size-selective aspects of glomerular permselectivity (2-4).
Ultrastructural studies have demonstrated aggregation of
HSPG into anionic sites in both the lamina rara externa and
lamina rara interna of glomerular basement membrane (1).
Previous reports have shown that glomerular epithelial cells
contribute to HSPG present in glomerular basement mem-
brane (5-7). Incubation of glomerular epithelial cells in medi-
um containing high glucose concentraion results in inhibi-
tion of synthesis of basement membrane HSPG, perlecan (8)
or agrin (9). High glucose medium induced reduction in syn-
thesis of perlecan was found to be mediated by regulation of
gene expression of perlecan core protein (10), suggesting a role
for glomerular epithelial cells in pathogenesis of proteinuria
in diabetic nephropathy.
Perlecan is an important species of HSPG present in the
basal laminae including the glomerular basement membrane
(11). It is a modular proteoglycan consisting of a large core
protein and heparan sulfate glycosaminoglycan (GAG) side
chains. Presence of HSPG in the subendothelial zone of the
glomerular basement membrane (lamina rara interna) (1)
suggests that glomerular endothelial cells (GEndo) may be
the source of the proteoglycan. Studies on bovine GEndo have
shown that the cells synthesize perlecan and release it into
the medium (12). The anionic site density in subendothelial
lamina rara interna of glomerular basement membrane is
reduced in diabetic nephropathy (1). This suggests that altered
metabolic activity of glomerular endothelial cells may be
involved in reduction of proteoglycans in the subendothelial
aspect of the diabetic glomerulus. Accordingly, we examined
whether high glucose medium regulates the GEndo meta-
bolism of basement membrane HSPG, perlecan.
MATERIALS AND METHODS
Cell Culture
Bovine GEndo were grown and characterized as previous-
ly described (12). Cells were grown to confluence and medi-
um changed to either (a) control medium: RPMI medium
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Regulation of Glomerular Endothelial Cell Proteoglycans by Glucose
The presence of heparan sulfate proteoglycan (HSPG) in anionic sites in the lamina
rara interna of glomerular basement membrane suggests that the proteoglycan may
be deposited by the glomerular endothelial cells (GEndo). We have previously demon-
strated that bovine GEndo in vitro synthesize perlecan, a species of glomerular base-
ment membrane HSPG. In this study we examined whether high glucose medium
regulates the GEndo metabolism of glycopeptides including perlecan. Metabolic
labeling of glycoconjugates with 
35S-SO4, sequential ion exchange and Sepharose
CL-4B chromatography of labeled glycoconjugates, and northern analysis were per-
formed. Incubation of GEndo for 8 to 14 weeks (but not for 1-2 weeks) in medium
containing 30 mM glucose resulted in nearly 50% reduction in the synthesis of cell
layer and medium 
35SO4-labeled low anionic glycoproteins and proteoglycans,
including that of basement membrane HSPG (Kav 0.42) compared to GEndo grown
in 5 mM glucose medium; no changes in anionic charge density or hydrodynamic
size of proteoglycans were noted. Northern analysis demonstrated that the mRNA
abundance of perlecan was reduced by 47% in cells incubated with 30 mM glucose.
Our data suggest that high glucose medium reduces the GEndo synthesis of per-
lecan by regulating its gene expression. Reduced synthesis of perlecan by GEndo
may contribute to proteinuria seen in diabetic nephropathy.
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containing 5 mM glucose, 0.66 unit/mL insulin, 10% fetal
bovine serum, 15 mM HEPES, 100  g/mL streptomycin,
100 U/mL penicillin, or, (b) high glucose medium: RPMI
medium containing 30 mM glucose, no added insulin, but
with all other additives as for control medium. These condi-
tions were designed to reflect features of type I diabetes, i.e.,
hyperglycemia and insulin lack. The cells were incubated in
an atmosphere of 5% CO2 at 37℃ in control, or high glu-
cose medium for 7 or 14 days for “short term” incubation.
In some experiments employing “long term” incubation,
GEndo were either grown to confluence and maintained in
5 mM or 30 mM glucose medium, or, were passed every 10-
14 days for 5 to 6 times and maintained in the respective
media for up to 2 to 3.5 months. The media were changed
every 3-4 days. In some experiments cells were grown in
medium containing 5 mM glucose and 25 mM mannitol to
serve as osmotic control for 30 mM glucose.
Analysis of Proteoglycans and Glycopeptides
Bovine GEndo glycoconjugates were systematically ana-
lyzed employing methods previously described (8, 12, 13).
Labeling with 
35SO4
At the end of either short or long term incubation, confluent
layers of GEndo grown in 12-well dishes were fed fresh con-
trol or high glucose medium and labeled for 24 hr with 200
Ci/mL of 35S-SO4 (ICN Biochemicals, Aurora, OH, U.S.A.;
specific activity 43 mCi/mg S, carrier free). Kasinath (12) has
previously shown that 35S-SO4 incorporation into macromole-
cules by the GEndo is linear up to 48 hr. Following labeling,
the medium and cell layer were extracted as previously de-
scribed (12). Guanidine HCl was added to the medium at a
concentration of 4 M along with the following protease in-
hibitors: 1 mM phenylmethylsulfonylfluoride, 100 mM 6-
aminohexanoic acid and 10 mM benzamidine HCl. Cell layers
were extracted overnight at 4℃ in 4 M guanidine HCl con-
taining 2% (3-[3-cholamidopropyl]-dimethylammonio)-1-
propane sulfate) (CHAPS) and protease inhibitors. Medium
and layer extracts were stored at -20℃until further analysis.
Protein content of the cell monolayers in parallel wells (n=4
in each experiment) incubated in the respective media was esti-
mated by using a bicinchonic acid reagent kit (Pierce, Rock-
ford, IL, U.S.A.), with bovine serum albumin as standard.
Purification of Labeled Macromolecules
The 35S-labeled macromolecules were separated from unin-
corporated free label by Sephadex G-25 chromatography using
pre-packed PD:10 columns (Pharmacia, Peepack, NJ, U.S.A.).
The elution buffer consisted of 6 M urea, 0.15 M NaCl, 0.05
M sodium acetate, protease inhibitors (as above), and, 0.5%
CHAPS, pH 5.8 (12). Aliquots of fractions were counted
in liquid scintillation medium (Aquassure, NEN Research,
Boston, MA, U.S.A.), and the excluded fractions were pooled
for analysis.
Ion Exchange Chromatography
35S-labeled proteoglycans were separated from low anionic
labeled macromolecules by DEAE-Sephacel chromatography.
Equal amounts (cpm) of pooled 35S-labeled cell or medium
macromolecules from each incubation condition were applied
to a DEAE-Sephacel column of 2 mL bed volume, and eluted
in 1 mL fractions along a linear NaCl gradient employing 6 M
urea buffer (see above) containing 0.15 M NaCl and 1.5 M
NaCl as start and limit buffers, respectively. Protease inhibitors
were included in both buffers. Gradient development was
monitored by measurement of conductivity of fractions using
CDM-80 instrument (Radiometer, Copenhagen, Denmark).
The fractions that elute at greater than 0.3 M NaCl were
pooled as proteoglycans (14).
Molecular Sieve Chromatography
Hydrodynamic size characteristics of proteoglycans were
studied by Sepharose CL-4B chromatography. Equal amounts
(cpm) of cell or medium labeled proteoglycans from each
condition of incubation were eluted in 1 mL fractions from
a 100×0.65-cm column of Sepharose CL-4B under dissoci-
ated conditions employing 4 M guanidine-HCl, 50 mM Tris-
HCl, pH 7.4, 0.5% Triton X-100 buffer containing protease
inhibitors. Aliquots of fractions were counted and fractions
corresponding to the peaks were pooled. The hydrodynamic
size of proteoglycans was calculated as Kav=Ve-Vo/Vt-Vo, were
Vo is the void volume as determined by blue dextran elution,
Vt is the total volume as determined by elution of free 3H-
glucosamine, and Ve is the elution volume of labeled proteo-
glycan.
Glycosaminoglycan (GAG) Digestion
Proteoglycans in each peak of Sepharose CL-4B chromato-
graphy were divided into three aliquots, and subjected to
chondroitinase-ABC or nitrous acid digestion as previously
described (8, 12); the third untreated aliquot served as a con-
trol. These conditions of have been shown to take enzymatic
digestions to completion (8, 12, 13). Following GAG diges-
tion gel chromatography was performed using a G:50 Sepha-
dex column with PBS as the elution buffer and relative pro-
portions of chondroitin/dermatan sulfate and heparan sulfate
GAGs were determined.
Northern Blot Analysis
Total RNA was extracted from GEndo incubated with 5
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mannitol medium (10, 15). RNA samples were quantified
by spectrophotometry and their integrity confirmed by elec-
trophoresis on 1% agarose gels. Equal amount of total RNA
(15  g) from GEndo incubated with the respective media
were fractionated on a 1% agarose, 2.2 M formaldehyde gel,
transferred to Nytran membrane using a TurboBlotter system
(Schleicher and Schuell, Keene, NH, U.S.A.), and cross-linked
by ultraviolet light. The membrane was prehybridized in a
buffer containing 50% formamide, 5×SSC, denatured salmon
sperm DNA 150  g/mL, sodium pyrophosphate-EDTA, at
42℃ with 1-2×106 cpm/mL of RPD-1, a partial cDNA for
rat perlecan (15). The blot was washed two times in 2×SSC,
0.1% SDS for 15 min at 45℃ and once in 0.2×SSC, 0.1%
SDS for 15 min at 50℃. The blot was autoradiographed on
an X-omat film using intensifying screens. The membrane
was stripped by boiling in 1% SDS, 10 mM EDTA, 10 mM
Tris buffer for 10 min and reprobed with a cDNA for GAPDH,
as described above. The intensity of bands was measured by
laser densitometric scanning (Hoefer Scientific Instruments,
San Francisco, CA, U.S.A.).
Statistics
The data (cpm per mg cell protein) in each condition of
incubation from three experiments were expressed as mean
±SEM and compared by Student’s t test; p<0.05 was con-
sidered to be statistically significant.
RESULTS
High Glucose Medium Decreases Synthesis of 
35S-SO4-
labeled Macromolecules
Following 24 hr of labeling in control medium approxi-
mately 47% of the total 35S-labeled macromolecules appeared
in the medium, the rest being retained in the cell layer. The
relative distribution of labeled macromolecules between the
medium and the cell layer compartments was unaffected by
incubation in high glucose medium (Table 1).
Following long term incubation (8 to 14 weeks) in high glu-
cose medium, the net synthesis of 35S-labeled macromolecules
was reduced by approximately 53% and 50% (p<0.05) in
both the medium and cell layer compartments, respectively.
Incubation in 30 mM glucose medium for 7 or 14 days did
not affect incorporation of 35S-SO4 into macromolecules (data
not shown). Careful attention was paid to possible untoward
effects of prolonged incubation periods on GEndo. Incorpo-
ration of 35S-SO4 into macromolecules by GEndo incubated
in control medium was quantitatively similar to our previ-
ous observations with GEndo (12), suggesting that the cells
were metabolically active despite prolonged incubation. Pro-
tein contents of cell layers did not differ significantly between
control and 30 mM glucose treated cell layers at the end of
incubation periods, i.e., 399±33.6  g/well (control, 30 mM
glucose) vs. 445±38.5  g/well (30 mM glucose, Table 1).
Finally, morphological examination at the end of prolonged
incubation did not reveal any difference in appearance between
cells grown in control or the high glucose media, the cells was
not noted on careful examination of the monolayers every
three days for the duration of incubation. The profile of pro-
teoglycans on molecular sieve chromatography was similar
to that reported in pure populations of GEndo (12), further
confirming absence of emergence of new cells with a differ-
ent proteoglycan profile. There was no evidence of excessive
cell detachment in cell layers incubated with 30 mM glu-
cose. These observations show that prolonged incubation with
30 mM glucose did not affect the viability of GEndo compared
to cell layers incubated for the same duration with medium
containing 5 mM glucose (Fig. 1).
High Glucose Medium Reduces Synthesis of 
35S-labeled
Glycoproteins and Proteoglycans
On ion exchange chromatography, 35S-labeled macromo-
lecules in both medium and cell layer of cells incubated with
5 mM glucose resolved into 2 peaks. Peak A appeared at a mo-
larity close to that of start buffer (0.15 M NaC1) whereas peak
B eluted at a molarity greater than 0.3 M NaC1 (Fig. 2, 3).
Proteoglycans accounted for the majority of labeled macro-
molecules in both medium and cell layer compartments. The
relative distribution of labeled macromolecules into peaks A
and B was not altered in GEndo incubated with 30 mM glu-
cose. However, high glucose medium induced a significant
53.5% reduction in the synthesis of 35S-labeled low anionic
macromolecules, i.e., glycoproteins (peak A) in cell layer com-
partment; although a 47% decrease was seen in the synthesis
of labeled glycoproteins in the medium, it did not achieve
statistical significance (Table 1).
Medium  Cell layer  Medium  Cell layer
5 mM glucose 30 mM glucose
Quantitative analysis of Glomerular Endothelial Cell
Glycopeptides
Protein contents
� 399±3.6 445±38.5 
35SO4 incorpo-
ration
� 46.7±5.79 53.3±5.79 21.91±3.85* 26.85±6.91
Ion exchange 
chromatography
�
Peak A 14.8±5.89 15.36±1.25 7.84±0.83 7.15±1.32
�
Peak B 31.9±2.27 37.94±4.6 14.07±4
� 19.70±5.71*
(proteoglycans)
*p<0.05, 
� p< 0.01 compared to 5 mM glucose, 
� Data of each cell lay-
ers ( g/well) from 8 experiments are presented as mean±SEM, 
�Com-
posite data (cpm×10
3 per mg cell protein) from 3 experiments are pre-
sented as mean±SEM.
Table 1. The incorporation of 
35S-SO4 into macromolecules in
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A significant reduction in the synthesis of 35S-labeled pro-
teoglycans was evident when cells were incubated with 30
mM glucose (Table 1) which was estimated at 56% for the
medium (31,900±2,270 vs. 14,070±4,000, p<0.01) and
at 48% for the cell layer compartment (37,940±4,600 vs.
19,700±5,710, p<0.05). Furthermore, high glucose medi-
um did not alter the anionic charge density of proteoglycans
in either the medium or the cell layer, as indicated by elu-
tion of peak B at similar molarity of NaC1 (Fig. 2, 3).
On molecular sieve chromatography, medium proteogly-
cans from GEndo incubated with 5 mM glucose resolved
into 2 peaks of Kav 0.18 and 0.42 (Fig. 4). Peak M-I (Kav
0.18) formed 36% of all medium proteoglycans whereas peak
M-II (Kav 0.42) accounted for the remainder (Table 2). GAG
analysis showed that the majority of proteoglycans in peaks
M-I and M-II was made of chondroitin sulfate proteoglycan
(76% and 59%, respectively) the remainder consisting of
heparan sulfate. The HSPG in peak M-II has the hydrody-
namic size of bovine glomerular basement membrane HSPG
(Kav 0.44) (16). On incubation with 30 mM glucose, there
was no alteration in either the hydrodynamic size of the pro-
teoglycan peaks M-I and M-II, or, their relative distribution
(Fig. 4). However, high glucose medium caused a reduction
in the synthesis of proteoglycans in peak M-I by 58% (11,430
±460 vs. 4,850±1,090, p<0.005) (Table 2). Similarly, a
55% reduction was seen in the synthesis of peak M-II, pro-
teoglycans (20,470±1,820 vs. 9,220±2,910, p<0.05) when
GEndo were incubated with 30 mM glucose medium (Table
2). GAG analysis showed that heparan sulfate accounted for
30% and 50% of peaks M-I and M-II respectively. The reduc-
tion in synthesis of HSPG in peak M-II that resembles glo-
merular basement membrane HSPG, perlecan, was estimat-
Fig. 1. Morphology of GEndo
undergoing prolonged incu-
bation in control medium con-
taining 5 mM and 30 mM
glucose. A B
5 mM 30 mM
Fig. 2. Ion exchange chromatography of medium 
35S-labeled macromolecules. Confluent layers of GEndo were incubated in medium
containing (A) 5 mM glucose or (B) 30 mM glucose for 8 to 14 weeks and labeled with 200  Ci/mL of 
35SO4 for 24 hr. Fractions containing
proteoglycans in peaks B were pooled as indicated by bars.
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Medium  Cell layer  Medium  Cell layer
5 mM glucose 30 mM glucose
Quantitative analysis of Glomerular Endothelial Cell 
Glycopeptides
Proteoglycans 31.9±2.27 37.94±4.6 14.07±4
� 19.7±5.71*
Peak I 11.43±0.46 6.39±0.99 4.85±1.09
� 4.73±1.04
Peak II 20.47±1.82 31.55±5.26 9.22±2.91* 14.97±4.72*
*p<0.05, 
� p< 0.01, 
� p< 0.005 compared to 5 mM glucose.
Composite data (cpm×10
3 per mg cell protein) from 3 experiments are
presented as mean±SEM.
Table 2. Proteoglycans in glomerular endothelial cells on molecu-
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ed at 45%.
Cell layer proteoglycans of GEndo incubated with control
medium also resolved into two distinct peaks of Kav 0.24 and
0.67, respectively (Fig. 5). Peak C-I of Kav 0.24 accounted
for 18% of all cell layer proteoglycans (Table 2). GAG anal-
ysis showed that heparan sulfate and chondroitin/dermatan
sulfate accounted for 54% and 46% of GAGs in peak C-I
(Kav 0.24), respectively, whereas peak C-II was composed
mostly of chondroitin/dermatan sulfate (73%). Incubation
with high glucose medium did not alter the hydrodynamic
size or the relative proportion of the proteoglycan peaks (Fig.
5). There was a reduction of approximately 26% in the syn-
thesis of peak C-I proteoglycans, which did not reach statis-
tical significance (Table 2). High glucose medium decreased
the synthesis of peak C-II proteoglycans significantly by 53%
(31,550±5,260 vs. 14,970±4,720, p<0.05) (Table 2). Incu-
bation with high glucose medium did not change the GAG
constituent profile of either peak. 
Regulation of Gene Expression of Perlecan, the Base-
ment Membrane HSPG, by High Glucose Medium
As there was a reduction in synthesis of HSPG that resem-
bles GBM HSPG, perlecan, we examined whether regulation
of perlecan gene expression could be involved. For northern
analysis, we employed RPD-1, a partial cDNA probe for rat
perlecan, which shares a high degree of homology with mouse
and human perlecan (15). As shown in Fig. 6, bovine GEndo
Fig. 3. Ion exchange chromatography of cell layer 
35S-labeled macromolecules. GEndo were incubated in medium containing (A) 5 mM
glucose or (B) 30 mM glucose for 8 to 14 weeks and labeled for 24 hr with 
35SO4 as in Fig. 2. Fractions containing proteoglycans in peaks
B were pooled as indicted by bars.
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Fig. 4. Sepharose CL-4B chromatography of medium proteoglycans. Equal amounts (cpm) of 
35S-labeled proteoglycans purified on ion
exchange chromatography (peaks B in Fig. 1) were subjected to Sepharose CL-4B chromatography using 4 M guanidine-HCI buffer con-
taining protease inhibitors. (A) medium proteoglycans from cells incubated with 5 mM glucose, (B) medium proteoglycans from cells incu-
bated with 30 mM glucose. Peaks M-I and M-II were pooled as indicated by bars for further analysis.
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constitutively express perlecan transcript which is approxi-
mately 12 kb in size (10). Following incubation with 30 mM
glucose for 12 weeks, there was a demonstrable reduction in
the mRNA abundance of perlecan. This was estimated to be
47% following correction for RNA loading as assessed by
hybridization with the probe for GAPDH. In contrast to the
high glucose medium, incubation for identical duration with
5 mM glucose with 25 mM mannitol, employed as an osmotic
control for 30 mM glucose, caused a 1.5-fold increase in the
mRNA abundance of perlecan in GEndo. 
DISCUSSION
These data demonstrate that prolonged incubation of bovine
GEndo with high glucose medium results in a decrease in the
synthesis of sulfated glycoproteins and proteoglycans, includ-
ing perlecan, a glomerular basement membrane HSPG. The
synthesis of perlecan is regulated at the level of gene expres-
sion. Metabolic effects of high glucose are selective and does
not due to an osmotic effect, as equimolar mannitol failed to
decrease the mRNA expression of perlecan.
It is generally thought that glomerular epithelial cells are
responsible for synthesis of glomerular basement membrane
in adult rats (5). Studies employing antibodies against laminin
have shown that both glomerular epithelial and endothelial
cells are involved in matrix synthesis in the developing rat
glomerulus; however, in the adult rat, glomerular epithelial
cells become the predominant source for laminin deposited in
the basement membrane (17). Endothelial cells are metaboli-
cally active cells that are known to contribute to synthesis of
extracellular matrix. The proximity of the anionic sites in
lamina rara interna to glomerular endothelial cells suggests
that GEndo could deposit HSPG in this location (1). Reduc-
tion in HSPG in the diabetic glomerulus has been shown to
involve its distribution in lamina rara interna (1). Our in vitro
observations support that GEndo contribute to reduction of
glomerular basement membrane content of perlecan in dia-
betic nephropathy. The mechanism underlying decreased
synthesis involves reduced gene expression although aug-
mented rate of degradation of perlecan cannot be excluded.
There are interesting similarities and differences in the regu-
lation of metabolism of 35S-labeled glycoconjugates between
the GEndo and glomerular epithelial cells when incubated
in high glucose medium. Following incubation of glomeru-
lar epithelial cells for 8 days in medium containing 30 mM
glucose, there was an increase in the synthesis of sulfated
glycoproteins and proteoglycans present in medium and cell
layer (8). The increased synthesis of 35S-labeled glycoproteins
in glomerular epithelial cell may contribute to glomerular
hypertrophic changes that predominantly involve extracellu-
Fig. 5. Sepharose CL-4B chromatography of cell layer proteoglycans. Equal amounts (cpm) of 
35S-labeled proteoglycans purified on ion
exchange chromatography (peaks B in Fig. 2) were subjected to Sepharose CL-4B chromatography using 4 M guanidine-HCI buffer con-
taining protease inhibitors. (A) cell layer proteoglycans from cells incubated with 30 mM glucose. Peaks C-I and C-II were pooled as indi-
cated by bars for further analysis.
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Fig. 6. Regulation of basement membrane HSPG, perlecan, mRNA
abundance in GEndo by high glucose medium. Top panel shows
bands of hybridization with RPD-1, a cDNA for perlecan, base-
ment membrane HSPG. Lower panel shows hybridization bands
with GAPDH probe.
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lar matrix. In contrast, high glucose medium caused a selec-
tive and significant reduction in synthesis of glomerular base-
ment membrane HSPG by glomerular epithelial cells (8). In
comparison with the glomerular epithelial cells, the response
of GEndo to high glucose medium was strikingly different.
There was a generalized reduction in the synthesis of 
35S-labeled
glycoproteins and proteoglycans, including the medium
HSPG species that resembles perlecan, a glomerular base-
ment membrane HSPG. Additionally, prolonged incubation
was needed for reduction in basement membrane HSPG syn-
thesis by GEndo whereas shorter incubation one and eight
days was sufficient with glomerular epithelial cells (10). These
observations suggest that while the reduction in HSPG con-
tent in basement membrane, reported to occur as early as 2
weeks in diabetic nephropathy (18), may be due to changes
in glomerular epithelial cell synthesis, the more sustained
reduction observed at later stages may involve decrease in the
synthesis of HSPG by both epithelial and endothelial cells.
It is possible that prolonged incubation in high glucose leads
to the formation of advanced glycated end-products (AGE)
or, at least, Amadori end-products. Voziyan et al. (19) demon-
strated that incubation of BSA with 30 mM glucose at 37℃
resulted in significant increase in the rate of accumulation
of Amadori intermediate and the kinetics was characterized
by t1/2-9 days. Therefore, GEndo maintained in 5 mM or
30 mM glucose medium for up to 2 to 3.5 months might
produce significant amount of Amadori intermediate and
AGE. Thus, the observed changes may not be due to direct
glucose effects. We recently showed that both high glucose
and AGE have reducing effects on the production of perlecan
core protein by glomerular epithelial cell in vitro (20). These
effects seemed to be additive. 
The mechanism by which high glucose medium decreas-
es the GEndo synthesis of glomerular basement membrane
HSPG involves regulation at the level of gene expression,
analogous to our observations with glomerular epithelial cells
(10). The mechanism by which high glucose medium affects
the mRNA abundance of HSPG core protein is not known
but may involve either reduced transcription and/or shortened
half-life of mRNA transcripts. A glucose response element
(GRE), with a consensus palindromic sequence CTCGTG,
has been identified in the promoter of a variety of glucose-
regulated genes including liver-type pyruvate kinase, fatty
acid synthase and spot-14 (21-23). GRE is involved in upregu-
lation of expression of the aforementioned genes, whereas
glucose inhibits the gene expression of HSPG in GEndo. It
is possible there are alternative sites of glucose regulation in
the promoter of basement membrane HSPG. Further inves-
tigation is needed to identify intermediary steps and effec-
tors involved in genetic regulation of basement membrane
HSPG by glucose.
The significance of reduced synthesis of 
35S-labeled glyco-
proteins by GEndo following incubation with high glucose
medium is unclear and is in contrast to the increment seen
with glomerular epithelial cells (8). Only a few of the sulfated
glycoproteins in basement membrane have been identified and
include entactin (nidogen) (24-26), laminin, and fibronectin
(27). In addition, there are several uncharacterized sulfated
glycoproteins in the range of 50-180 kDa (28, 29). Glomeru-
lar entactin content is increased in diabetic nephropathy (26).
Recent observations from our laboratory have suggested that
mesangial laminin content is increased in nephropathy in rats
with streptozotocin-induced diabetes and db/db mice with
spontaneous type II diabetes (30). Additional studies are needed
to identify the sulfated glycoproteins synthesized by GEndo.
It is possible that the content of some of the hitherto unidenti-
fied sulfated glycoproteins is reduced in the diabetic glomeru-
lar basement membrane.
The reduction of HSPG synthesis by GEndo could con-
tribute to proteinuria in diabetic nephropathy. Vernier et al.
(1) have demonstrated a significant linear relationship between
urinary albumin excretion and heparan sulfate enriched anion-
ic sites in lamina rara interna in diabetic nephropathy. The
mechanisms underlying dysregulation in GEndo HSPG
metabolism are unknown and could include derangements
in polyol metabolism (31, 32), nonenzymatic glycation (33)
or cytokines such as TGF- (34). Our data suggest that
GEndo in vitro are an appropriate model to further investigate
mechanisms involved in dysregulation of basement mem-
brane HSPG synthesis in diabetic nephropathy.
ACKNOWLEDGMENT
We thank Mrs. Carolyn Bryan for excellent secretarial assis-
tance. This work was supported by grants from Veterans’
Administration (BSK), and the American Diabetes Associa-
tion (BSK), the NIH DK 33665 (HEA), Korean Ministry
of Health and Welfare (HMP-98-M-5-0053), and Korea
Science and Engineering Foundation (KOSEF, R01-2002-
000-00251-0).
REFERENCES
1. Vernier RL, Steffes MW, Sisson-Ross S, Mauer SM. Heparan sul-
fate proteoglycan in the glomerular basement membrane of type I
diabetes mellitus. Kidney Int 1992; 41: 1070-80.
2. Kanwar YS, Linker A, Farquhar MG. Increased permeability of the
glomerular basement membrane to ferritin after removal of glycosa-
minoglycans (heparan sulfate) by enzyme digestion. J Cell Biol 1980;
86: 688-93.
3. Rosenzweig LJ, Kanwar YS. Removal of sulfated (heparan sulfate)
and nonsulfated (hyaluronic acid) glycosaminoglycans results in in-
creased permeability of the glomerular basement membrane to 
125I-
bovine serum albumin. Lab Invest 1982; 47: 177-84.
4. Kasinath BS, Kanwar YS. Glomerular Basement Membrane: Biolo-
gy and Physiology. In: Rohrbach DH, Timpl R, editors, Molecular252 T.-S. Ha, S. Duraisamy, J. L. Faulkner, et al.
and Cellular Aspects of Basement Membrane. San Diego: Academic
Press, 1993; 89-106.
5. Stow JL, Sawada H, Farquhar MG. Basement membrane heparan
sulfate proteoglycans are concentrated in the laminae rarae and in
podocytes of the rat renal glomerulus. Proc Natl Acad Sci USA 1985;
82: 3296-300.
6. Thomas GJ, Jenner L, Mason RM, Davies M. Human glomerular
epithelial cell proteoglycans. Arch Biochem Biophys 1990; 278: 11-20.
7. Klein DJ, Oegema TR Jr., Fredeen TS, van der Woude F, Kim Y,
Brown DM. Partial characterization of proteoglycans synthesized
by human glomerular epithelial cells in culture. Arch Biochem Bio-
phys 1990; 277: 389-401.
8. Kasinath BS, Block JA, Singh AK, Terhune WC, Maldonado R,
Davalath S, Kallgren MJ, Wanna L. Regulation of rat glomerular
epithelial cell proteoglycans by high glucose medium. Arch Biochem
Biophys 1994; 309: 149-59.
9. Yard BA, Kahlert S, Engelleiter R, Resch S, Waldherr R, Groffen
AJ, van den Heuvel LP, van der Born J, Berden JH, Kroger S, Hafner
M, van der Woude FJ. Decreased glomerular expression of agrin in
diabetic nephropathy and podocytes, cultured in high glucose medi-
um. Exp Nephrol 2001; 9: 214-22.
10. Kasinath BS, Grellier P, Choudhury GG, Abboud SL. Regulation of
basement membrane heparan sulfate proteoglycan, perlecan, gene
expression in glomerular epithelial cells by high glucose medium. J
Cell Physiol 1996; 167: 131-6.
11. Iozzo RV, Murdoch AD. Proteoglycans of the extracellular environ-
ment: clues from the gene and protein side offer novel perspectives
in molecular diversity and function. FASEB J 1996; 10: 598-614.
12. Kasinath BS. Glomerular endothelial cell proteoglycans: Regulation
by TGF  -1. Arch Biochem Biophys 1993; 305: 370-7.
13. Kasinath BS. Effect of insulin on high glucose medium induced
changes in rat glomerular epithelial cell metabolism of glycoconju-
gates. Arch Biochem Biophys 1995; 318: 286-94.
14. Yanagishita M, Midura RJ, Hascall VC. Proteoglycans: Isolation
and purification from tissue cultures. Methods Enzymol 1987; 138:
279-89.
15. Ko CW, Bhandari B, Yee J, Terhune WC, Maldonado R, Kasinath
BS. Cyclic AMP regulates basement membrane heparan sulfate
proteoglycan, perlecan, metabolism in rat glomerular epithelial
cells. Mol Cell Biochem 1996; 162: 65-73. 
16. Parthasarathy N, Spiro RG. Isolation and characterization of the hep-
aran sulfate proteoglycan of the bovine glomerular basement mem-
brane. J Biol Chem 1984; 259: 12749-55.
17. Abrahamson DR. Origin of the glomerular basement membrane
visualized after in vivo labeling of laminin in newborn rat kidneys. J
Cell Biol 1981; 100: 1988-2000.
18. Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J,
Couser WG, Seidel K. Cellular events in the evolution of experimen-
tal diabetic nephropathy. Kidney Int 1995; 47: 935-44.
19. Voziyan PA, Khalifah RG, Thibaudeau C, Yildiz A, Jacob J, Serianni
AS, Hudson BG. Modification of proteins in vitro by physiological
levels of glucose: pyridoxamine inhibits conversion of Amadori inter-
mediate to advanced glycation end-products through binding of redox
metal ions. J Biol Chem 2003; 278: 46616-24.
20. Ha T-S, Kim H-S. Effects of advanced glycation endproducts on rat
glomerular epithelial cells: Roles of reactive oxygen species. Korean
J Nephrol 2003; 22: 285-93.
21. Thompson KS, Towle HC. Localization of the carbohydrate response
element of the rat L-type pyruvate kinase gene. J Biol Chem 1991;
266: 8679-82.
22. Shin HM, Towle HC. Definition of carbohydrate response element of
the rat S14 gene. Evidence for a common factor required for carbo-
hydrate regulation of hepatic genes. J Biol Chem 1992; 267: 13222-8.
23. Vaulont S, Kahn A. Transcriptional control of metabolic regulation
genes by carbohydrates. FASEB J 1994; 8: 28-35.
24. Carlin B, Jaffe R, Bender B, Chung AE. Entactin, a novel basal lami-
na-associated glycoprotein. J Biol Chem 1981; 256: 5209-14.
25. Timpl R, Dziadek M, Fujiwara S, Nowack H, Wick G. Nidogen: a
new self-aggregating basement membrane protein. Eur J Biochem
1983; 137: 455-65.
26. Katz A, Fish AJ, Kleppel MM, Hagen SG, Michael AF, Butkowski
RJ. Renal entactin (nidogen): isolation, characterization and tissue
distribution. Kidney Int 1991; 40: 643-52.
27. Hogan BL, Taylor A, Kurkinen M, Couchman JR. Synthesis and
localization of two sulphated glycoproteins associated with basement
membranes and the extracellular matrix. J Cell Biol 1982; 95: 197-
204.
28. Cohen MP, Wu VY, Surma ML. Non-collagen protein and proteo-
glycan in renal glomerular basement membrane. Biochem Biophys
Acta 1981; 678: 322-8.
29. Lemkin MC, Farquhar MG. Sulfated and nonsulfated glycosamino-
glycans and glycopeptides are synthesized by kidney in vivo and in-
corporated into glomerular basement membranes. Proc Natl Acad
Sci USA 1981; 78: 1726-30.
30. Ha T-S, Barnes JL, Stewart JL, Ko CW, Miner JH, Abrahamson DR,
Sanes JR, Kasinath BS. Regulation of renal laminin in mice with
type II diabetes. J Am Soc Nephrol 1999; 10: 1931-9.
31. Tilton RG, Chang K, Pugliese G, Eades DM, Province MA, Sherman
WR, Kilo C, Williamson JR. Prevention of hemodynamic and vas-
cular albumin filtration changes in diabetic rats by aldose reductase
inhibitors. Diabetes 1989; 38: 1258-70.
32. Pugliese G, Tilton RG, Speedy A, Santarelli E, Eades DM, Province
MA, Kilo C, Sherman WR, Williamson JR. Modulation of hemody-
namic and vascular filtration changes in diabetic rats by dietary
myo-inositol. Diabetes 1990; 39: 312-22.
33. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced
glycosylation: biochemical, biological and clinical implications for
diabetes and aging. Lab Invest 1993; 70: 138-51.
34. Ziyadeh FN, Sharma K, Ericksen M, Wolf G. Stimulation of colla-
gen gene expression and protein synthesis in murine mesangial
cells by high glucose is mediated by autocrine activation of trans-
forming growth factor- . J Clin Invest 1994; 93: 536-42.